Clinical Trial Update: Cytoreductive Surgery (CRS) With/Without HIPEC in Gastric Cancer With Peritoneal Carcinomatosis [Phase 3]

View source ↗

Summary

Phase 3 trial update on cytoreductive surgery with or without HIPEC for gastric cancer with peritoneal carcinomatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Peritoneal Carcinomatosis

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Malignant Neoplasm of Stomach, Secondary Malignant Neoplasm of Peritoneum | Phase 3 | Status: COMPLETED